Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Teng

Showing results (241-250 of 249) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 249 results.
Oncotarget|February 11, 2017
An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cellsMin-Wu Chao, Han-Li Huang, Wei-Chun HuangFu, et al.
Reproductive Biology and Endocrinology : RB&E|August 19, 2022
A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatmentChuan Ling Tang, Qi Yue Li, Feng Lian Chen, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|November 12, 2005
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]Zheng Li, Guo-wu Chen, Xue-jun Shang, et al.
Journal of Medicinal Chemistry|June 15, 2011
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agentsXiaoming Yang, Qian Shi, Shuenn-Chen Yang, et al.
Journal of Medicinal Chemistry|January 28, 2010
Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agentLi-Chen Chou, Chien-Ting Chen, Jang-Chang Lee, et al.
Carcinogenesis|February 25, 2016
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancerEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Journal of Medicinal Chemistry|February 13, 2010
Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analoguesYizhou Dong, Qian Shi, Huei-Chen Pai, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Cancer Cell|November 16, 2016
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5Hui-Lung Sun, Ri Cui, JianKang Zhou, et al.
Pageof 25

Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
Oncotarget|February 11, 2017
An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cellsMin-Wu Chao, Han-Li Huang, Wei-Chun HuangFu, et al.
Reproductive Biology and Endocrinology : RB&E|August 19, 2022
A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatmentChuan Ling Tang, Qi Yue Li, Feng Lian Chen, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|November 12, 2005
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]Zheng Li, Guo-wu Chen, Xue-jun Shang, et al.
Journal of Medicinal Chemistry|June 15, 2011
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agentsXiaoming Yang, Qian Shi, Shuenn-Chen Yang, et al.
Journal of Medicinal Chemistry|January 28, 2010
Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agentLi-Chen Chou, Chien-Ting Chen, Jang-Chang Lee, et al.
Carcinogenesis|February 25, 2016
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancerEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Journal of Medicinal Chemistry|February 13, 2010
Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analoguesYizhou Dong, Qian Shi, Huei-Chen Pai, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Cancer Cell|November 16, 2016
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5Hui-Lung Sun, Ri Cui, JianKang Zhou, et al.
Pageof 25